• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV 感染与 COVID-19 死亡:基于人群的英国初级保健数据队列分析及 OpenSAFELY 平台内的全国死亡登记数据关联分析

HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.

机构信息

Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.

Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, UK.

出版信息

Lancet HIV. 2021 Jan;8(1):e24-e32. doi: 10.1016/S2352-3018(20)30305-2. Epub 2020 Dec 11.

DOI:10.1016/S2352-3018(20)30305-2
PMID:33316211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7773630/
Abstract

BACKGROUND

Whether HIV infection is associated with risk of death due to COVID-19 is unclear. We aimed to investigate this association in a large-scale population-based study in England.

METHODS

We did a retrospective cohort study. Working on behalf of NHS England, we used the OpenSAFELY platform to analyse routinely collected electronic primary care data linked to national death registrations. We included all adults (aged ≥18 years) alive and in follow-up on Feb 1, 2020, and with at least 1 year of continuous registration with a general practitioner before this date. People with a primary care record for HIV infection were compared with people without HIV. The outcome was COVID-19 death, defined as the presence of International Classification of Diseases 10 codes U07.1 or U07.2 anywhere on the death certificate. Cox regression models were used to estimate the association between HIV infection and COVID-19 death; they were initially adjusted for age and sex, then we added adjustment for index of multiple deprivation and ethnicity, and then for a broad range of comorbidities. Interaction terms were added to assess effect modification by age, sex, ethnicity, comorbidities, and calendar time.

RESULTS

17 282 905 adults were included, of whom 27 480 (0·16%) had HIV recorded. People living with HIV were more likely to be male, of Black ethnicity, and from a more deprived geographical area than the general population. 14 882 COVID-19 deaths occurred during the study period, with 25 among people with HIV. People living with HIV had higher risk of COVID-19 death than those without HIV after adjusting for age and sex: hazard ratio (HR) 2·90 (95% CI 1·96-4·30; p<0·0001). The association was attenuated, but risk remained high, after adjustment for deprivation, ethnicity, smoking and obesity: adjusted HR 2·59 (95% CI 1·74-3·84; p<0·0001). There was some evidence that the association was larger among people of Black ethnicity: HR 4·31 (95% CI 2·42-7·65) versus 1·84 (1·03-3·26) in non-Black individuals (p-interaction=0·044).

INTERPRETATION

People with HIV in the UK seem to be at increased risk of COVID-19 mortality. Targeted policies should be considered to address this raised risk as the pandemic response evolves.

FUNDING

Wellcome, Royal Society, National Institute for Health Research, National Institute for Health Research Oxford Biomedical Research Centre, UK Medical Research Council, Health Data Research UK.

摘要

背景

HIV 感染是否与 COVID-19 死亡风险相关尚不清楚。我们旨在通过在英格兰的一项大规模基于人群的研究中对此进行研究。

方法

我们进行了回顾性队列研究。代表 NHS 英格兰,我们使用 OpenSAFELY 平台分析了与国家死亡登记相关的常规收集的电子初级保健数据。我们纳入了所有在 2020 年 2 月 1 日存活且正在随访的成年人(年龄≥18 岁),并且在此日期之前至少有 1 年的全科医生连续登记。有初级保健记录的 HIV 感染者与没有 HIV 的人进行了比较。COVID-19 死亡的结局定义为死亡证明上存在国际疾病分类第 10 编码 U07.1 或 U07.2。Cox 回归模型用于估计 HIV 感染与 COVID-19 死亡之间的关联;最初按年龄和性别进行调整,然后按多个剥夺指数和种族进行调整,然后按广泛的合并症进行调整。添加交互项以评估年龄、性别、种族、合并症和日历时间的效应修饰。

结果

纳入了 17282905 名成年人,其中 27480 人(0.16%)有 HIV 记录。与一般人群相比,HIV 感染者更有可能是男性、黑人,并且来自较贫困的地区。在研究期间发生了 14882 例 COVID-19 死亡,其中 25 例发生在 HIV 感染者中。与没有 HIV 的人相比,HIV 感染者在调整年龄和性别后 COVID-19 死亡的风险更高:风险比(HR)为 2.90(95%CI 1.96-4.30;p<0.0001)。在调整剥夺程度、种族、吸烟和肥胖后,关联减弱,但风险仍然很高:调整后的 HR 为 2.59(95%CI 1.74-3.84;p<0.0001)。有一些证据表明,这种关联在黑人中更大:HR 为 4.31(95%CI 2.42-7.65),而非黑人中为 1.84(1.03-3.26)(p 交互=0.044)。

解释

英国的 HIV 感染者似乎 COVID-19 死亡率更高。随着大流行应对措施的发展,应考虑制定有针对性的政策来解决这一高风险问题。

经费

惠康基金会、皇家学会、英国国家卫生研究院、英国国家卫生研究院牛津生物医学研究中心、英国医学研究理事会、英国健康数据研究中心。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/7831815/524acf327e64/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/7831815/9168a58406c8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/7831815/7d5533a6beb7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/7831815/524acf327e64/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/7831815/9168a58406c8/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/7831815/7d5533a6beb7/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/279f/7831815/524acf327e64/gr3_lrg.jpg

相似文献

1
HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.HIV 感染与 COVID-19 死亡:基于人群的英国初级保健数据队列分析及 OpenSAFELY 平台内的全国死亡登记数据关联分析
Lancet HIV. 2021 Jan;8(1):e24-e32. doi: 10.1016/S2352-3018(20)30305-2. Epub 2020 Dec 11.
2
Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.在英格兰 1700 万成年人中,观察性队列研究使用 OpenSAFELY 平台发现 SARS-CoV-2 感染以及与 COVID-19 相关的住院、重症监护病房入院和死亡的种族差异。
Lancet. 2021 May 8;397(10286):1711-1724. doi: 10.1016/S0140-6736(21)00634-6. Epub 2021 Apr 30.
3
Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform.与2019冠状病毒病相关死亡与其他原因导致死亡的相关因素:基于人群的队列分析,涉及英国初级医疗数据以及OpenSAFELY平台内相关的国家死亡登记信息
Lancet Reg Health Eur. 2021 Jul;6:100109. doi: 10.1016/j.lanepe.2021.100109. Epub 2021 May 8.
4
Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study.牛津皇家全科医生学院研究和监测中心初级保健网络中 SARS-CoV-2 患者的风险因素:一项横断面研究。
Lancet Infect Dis. 2020 Sep;20(9):1034-1042. doi: 10.1016/S1473-3099(20)30371-6. Epub 2020 May 15.
5
Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.英格兰 1 型和 2 型糖尿病患者 COVID-19 相关死亡率的风险因素:一项基于人群的队列研究。
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833. doi: 10.1016/S2213-8587(20)30271-0. Epub 2020 Aug 13.
6
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.在英格兰,COVID-19 住院后整体和特定病因的住院和死亡:使用 OpenSAFELY 平台中的链接初级保健、二级保健和死亡登记数据进行的队列研究。
PLoS Med. 2022 Jan 25;19(1):e1003871. doi: 10.1371/journal.pmed.1003871. eCollection 2022 Jan.
7
Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform.在使用 OpenSAFELY 平台的观察性队列研究中,接受吸入皮质类固醇治疗的慢性阻塞性肺疾病或哮喘患者发生 COVID-19 相关死亡的风险。
Lancet Respir Med. 2020 Nov;8(11):1106-1120. doi: 10.1016/S2213-2600(20)30415-X. Epub 2020 Sep 24.
8
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
9
Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.与免疫介导的炎症性疾病和免疫调节疗法相关的重症 COVID-19 结局风险:OpenSAFELY 平台的一项全国性队列研究
Lancet Rheumatol. 2022 Jul;4(7):e490-e506. doi: 10.1016/S2665-9913(22)00098-4. Epub 2022 Jun 9.
10
Trends in weight gain recorded in English primary care before and during the Coronavirus-19 pandemic: An observational cohort study using the OpenSAFELY platform.在冠状病毒-19 大流行之前和期间记录的英国初级保健中体重增加的趋势:使用 OpenSAFELY 平台的观察性队列研究。
PLoS Med. 2024 Jun 24;21(6):e1004398. doi: 10.1371/journal.pmed.1004398. eCollection 2024 Jun.

引用本文的文献

1
COVID-19 Incidence and Factors Influencing Infection Risk Among People Living With HIV in Türkiye: Is Current Issue the Vaccine Hesitancy-Opposition?土耳其艾滋病毒感染者中的新冠肺炎发病率及影响感染风险的因素:当前问题是疫苗犹豫/反对吗?
Can J Infect Dis Med Microbiol. 2025 Aug 18;2025:6767853. doi: 10.1155/cjid/6767853. eCollection 2025.
2
Bringing optimised COVID-19 vaccine schedules to immunocompromised populations: statistical elements and design.为免疫功能低下人群制定优化的COVID-19疫苗接种计划:统计要素与设计
Trials. 2025 Jul 25;26(1):256. doi: 10.1186/s13063-025-08965-w.
3
A cross-section study of the relationship between lifestyles and severity of COVID-19 symptoms in people living with HIV.

本文引用的文献

1
COVID-19 in Immunocompromised Hosts: What We Know So Far.免疫功能低下宿主中的 COVID-19:目前我们已知的情况。
Clin Infect Dis. 2021 Jan 27;72(2):340-350. doi: 10.1093/cid/ciaa863.
2
Collider bias undermines our understanding of COVID-19 disease risk and severity.撞击器偏差破坏了我们对 COVID-19 疾病风险和严重程度的理解。
Nat Commun. 2020 Nov 12;11(1):5749. doi: 10.1038/s41467-020-19478-2.
3
Outcomes of Coronavirus Disease 2019 (COVID-19) Related Hospitalization Among People With Human Immunodeficiency Virus (HIV) in the ISARIC World Health Organization (WHO) Clinical Characterization Protocol (UK): A Prospective Observational Study.
一项关于HIV感染者生活方式与COVID-19症状严重程度之间关系的横断面研究。
Sci Rep. 2025 May 20;15(1):17464. doi: 10.1038/s41598-025-99528-1.
4
Rapid development of a registry to accelerate COVID-19 vaccine clinical trials.快速建立一个登记系统以加速新冠疫苗临床试验。
NPJ Digit Med. 2025 May 6;8(1):251. doi: 10.1038/s41746-025-01666-3.
5
Distinct immune responses in people living with HIV following SARS-CoV-2 recovery.SARS-CoV-2感染康复后的HIV感染者的不同免疫反应。
Commun Med (Lond). 2025 Apr 23;5(1):132. doi: 10.1038/s43856-025-00839-1.
6
COVID-19 vaccine utilisation among people living with HIV on antiretroviral therapy in Zimbabwe.津巴布韦接受抗逆转录病毒治疗的艾滋病毒感染者中新冠病毒疫苗的接种情况
J Public Health Afr. 2025 Mar 11;16(1):664. doi: 10.4102/jphia.v16i1.664. eCollection 2025.
7
The next viral pandemic-where do we stand?下一场病毒性大流行——我们目前的状况如何?
Folia Microbiol (Praha). 2025 Mar 28. doi: 10.1007/s12223-025-01256-6.
8
Macrovascular Function in People with HIV After Recent SARS-CoV-2 Infection.近期感染SARS-CoV-2的HIV感染者的大血管功能
J Vasc Dis. 2025 Mar;4(1). doi: 10.3390/jvd4010004. Epub 2025 Jan 26.
9
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV.成人艾滋病病毒感染者中严重急性呼吸综合征冠状病毒2抗体的流行情况
AIDS. 2025 Jul 15;39(9):1178-1184. doi: 10.1097/QAD.0000000000004180. Epub 2025 Mar 13.
10
Spatial analysis of COVID-19 incidence and mortality rates in northwest iran for future epidemic preparedness.伊朗西北部COVID-19发病率和死亡率的空间分析,以做好未来疫情防范准备。
Sci Rep. 2025 Mar 3;15(1):7450. doi: 10.1038/s41598-025-91246-y.
在 ISARIC 世界卫生组织(WHO)临床特征协议(英国)中,人类免疫缺陷病毒(HIV)感染者因 2019 年冠状病毒病(COVID-19)相关住院的结果:一项前瞻性观察研究。
Clin Infect Dis. 2021 Oct 5;73(7):e2095-e2106. doi: 10.1093/cid/ciaa1605.
4
Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.南非西开普省人群队列研究中 2019 冠状病毒病(COVID-19)死亡的危险因素。
Clin Infect Dis. 2021 Oct 5;73(7):e2005-e2015. doi: 10.1093/cid/ciaa1198.
5
Coronavirus disease 2019 (COVID-19) outcomes in HIV/AIDS patients: a systematic review.新型冠状病毒病 2019(COVID-19)在艾滋病毒/艾滋病患者中的结局:一项系统评价。
HIV Med. 2020 Oct;21(9):567-577. doi: 10.1111/hiv.12911. Epub 2020 Jul 15.
6
Factors associated with COVID-19-related death using OpenSAFELY.使用 OpenSAFELY 分析与 COVID-19 相关死亡的因素。
Nature. 2020 Aug;584(7821):430-436. doi: 10.1038/s41586-020-2521-4. Epub 2020 Jul 8.
7
The impact of ethnicity on clinical outcomes in COVID-19: A systematic review.种族对新冠病毒病临床结局的影响:一项系统评价
EClinicalMedicine. 2020 Jun 3;23:100404. doi: 10.1016/j.eclinm.2020.100404. eCollection 2020 Jun.
8
Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City.2019 年冠状病毒和人类免疫缺陷病毒感染者:纽约市住院患者的结局。
Clin Infect Dis. 2020 Dec 31;71(11):2933-2938. doi: 10.1093/cid/ciaa880.
9
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort.描述感染 HIV 的个体中的 COVID-19:单中心前瞻性队列研究。
Lancet HIV. 2020 Aug;7(8):e554-e564. doi: 10.1016/S2352-3018(20)30164-8. Epub 2020 May 28.
10
Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019.2019年冠状病毒病住院的人类免疫缺陷病毒感染者的临床特征及预后
Clin Infect Dis. 2020 Nov 19;71(16):2294-2297. doi: 10.1093/cid/ciaa635.